MWEFX | RWBEX | MWEFX / RWBEX | |
Total Expense Ratio | 1.15 | 1.21 | 95% |
Annual Report Gross Expense Ratio | 1.18 | 1.21 | 98% |
Fund Existence | 32 years | 11 years | - |
Gain YTD | 6.143 | 8.807 | 70% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.18B | 131B | 2% |
Annual Yield % from dividends | 0.74 | 1.11 | 66% |
Returns for 1 year | -4.19 | 5.84 | -72% |
Returns for 3 years | 2.05 | 42.36 | 5% |
Returns for 5 years | 9.19 | 49.52 | 19% |
Returns for 10 years | 29.56 | 49.42 | 60% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTCX | 20.46 | -0.13 | -0.63% |
Fidelity Advisor Biotechnology C | |||
AZNCX | 9.52 | -0.06 | -0.63% |
Virtus Income & Growth C | |||
MSBVX | 11.93 | -0.15 | -1.24% |
Morgan Stanley American Resilience I | |||
NCIGX | 30.98 | -0.41 | -1.31% |
Nuveen International Value C | |||
MNHWX | 26.13 | -0.41 | -1.54% |
Manning & Napier Pro-Blend Max Term W |